Aurinia Pharmaceuticals Inc - Common Shares (AUPH)
Healthcare › Pharmaceutical Preparations
Price History
Feb 9, 2026 — Jul 6, 2026Investment Snapshot
- Trading 12% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 5/9 — moderate financial health
- Strong ROE of 52.5% with 100.0% net margin
- Revenue growing at 20% annually
Aurinia Pharmaceuticals Inc - Common Shares (AUPH) is a Healthcare company operating in Pharmaceutical Preparations, listed on the NASDAQ , with a market capitalisation of $2.2 billion . Key value metrics: P/E ratio 7.3, P/B ratio 3.84, Piotroski F-Score 5 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Aurinia Pharmaceuticals Inc - Common Shares — Fundamental Analysis Summary
Aurinia Pharmaceuticals Inc - Common Shares (AUPH) is currently trading 12% above its Graham Number of $15.18, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries a low trailing P/E ratio of 7.3x.
On financial health, AUPH shows a moderate Piotroski F-Score of 5/9, and strong return on equity of 52.5% (sector average: -20.6%), and minimal leverage with a debt-to-equity ratio of 0.29.
StockPik's composite Value Score for AUPH is 99/100 — placing it in undervalued territory. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
AUPH reports a high gross margin of 89.8% (sector average: 39.4%) and a strong operating margin of 41.7%.
AUPH shows revenue growing at 20% year-over-year, with earnings growing at 4,893%.